Split comparison diagram showing skin booster intradermal hydration mechanism on the left versus dermal filler volumising bolus on the right

Skin Boosters vs Dermal Fillers: Understanding the Clinical Difference

Skin boosters and dermal fillers are both injectable HA products. They are often displayed side by side in clinic price lists, administered by the same practitioners, and occasionally confused by patients — and even, more problematically, by practitioners — as interchangeable treatments. They are not.

Illustration of antibody molecules interacting with botulinum toxin protein representing immunogenicity and toxin resistance concept

Botulinum Toxin Resistance and Antibody Formation: Clinical Implications

This guide covers the clinical science of botulinum toxin resistance: what causes it, how to distinguish true immunological non-response from pseudo-resistance, which products carry the lowest immunogenicity risk, and how to manage patients who have developed or are developing resistance. It is one of the most clinically important topics in long-term toxin practice, and one that becomes increasingly relevant as patient treatment histories lengthen.